Discontinuation report VOLTAREN
Report ID | 8504 |
Drug Identification Number | 00632732 |
Brand name | VOLTAREN SUP 100MG |
Common or Proper name | VOLTAREN 100MG SUPPOSITORY (5X6) |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | DICLOFENAC SODIUM |
Strength(s) | 100MG |
Dosage form(s) | SUPPOSITORY |
Route of administration | RECTAL |
Packaging size | 5 X 6 |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-06-01 |
Actual discontinuation date | 2017-07-25 |
Remaining supply date | 2017-06-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-11-02 | French | Compare |
v5 | 2017-11-02 | English | Compare |
v4 | 2017-05-02 | French | Compare |
v3 | 2017-05-02 | English | Compare |
v2 | 2017-05-01 | French | Compare |
v1 | 2017-05-01 | English | Compare |
Showing 1 to 6 of 6